Equillium Announces Positive Topline Results From The EQUATE Study In

Equillium Press Release Gradient Gliders

equillium reports first quarter 2021 financial results and provides clinical to treat severe autoimmune รข equillium inc announced positive topline data nbsp

Equillium Presents Positive Interim Clinical Data Of Itolizumab In

12 feb 2021 building on favorable safety data and durable response rates demonstrated so far we look forward to the topline data results of the equate nbsp

Gannex Announces Positive Topline Results Of The U S Phase I

3 days ago gannex announces positive topline results of the u s phase i trial of nash drug asc42 an fxr agonist no pruritus observed during nbsp

Bristol Myers Squibb

10 jun 2021 bristol myers squibb announces positive topline results from phase 3 transform trial evaluating breyanzi lisocabtagene maraleucel nbsp

Beigene Announces Positive Topline Results From Phase 3 Trial Of

21 may 2021 beigene announces positive topline results from phase 3 trial of tislelizumab in combination with chemotherapy as first line treatment for nbsp

Pfizer Announces Positive Topline Results From Second Phase 3

pfizer announces positive topline results from second phase 3 lipid lowering study evaluating bococizumab spire ai study evaluating bococizumab nbsp

Maat Pharma Announces Positive Topline Results From Phase 2

17 mar 2021 announced today positive topline results from its phase 2 clinical trial evaluating lead microbiome ecosystem therapy maat013 in a high risk nbsp

Equillium Announces Positive Topline Results From The

11 jun 2021 equillium announces positive topline results from the equate study in first line treatment of acute graft versus host disease june 11 nbsp

Equillium Eq Announces Positive Topline Results From The

11 jun 2021 equillium eq announces positive topline results from the equate study in first line treatment of acute graft versus host disease

Equillium Announces Positive Topline Results From The Equate

11 jun 2021 equillium inc eq equillium announces positive topline results from the equate study in first line treatment of acute graft versus host nbsp